Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis
Biofrontera Inc. (NASDAQ:BFRI) and Almirall have launched the Hats On Challenge, a social media initiative to raise awareness about Actinic Keratosis (AK) ahead of Global AK Awareness Day on May 24, 2025. The campaign aims to support The Skin Cancer Foundation and Euromelanoma through a social media challenge where participants wear hats and post videos using specific hashtags.
AK is a common precancerous skin condition affecting an estimated 58 million Americans, with a global prevalence of 14%. The condition, characterized by rough, scaly patches on sun-exposed areas, can develop into squamous cell carcinoma if left untreated. The campaign will run throughout May 2025, with both companies making monetary donations to The Skin Cancer Foundation on behalf of participants.
Biofrontera Inc. (NASDAQ:BFRI) e Almirall hanno lanciato la Hats On Challenge, un'iniziativa sui social media per sensibilizzare sull'cheratosi attinica (AK) in vista della Giornata Mondiale di Sensibilizzazione sull'AK del 24 maggio 2025. La campagna sostiene The Skin Cancer Foundation e Euromelanoma attraverso una sfida social in cui i partecipanti indossano cappelli e pubblicano video utilizzando hashtag specifici.
L'AK è una comune condizione cutanea precancerosa che colpisce circa 58 milioni di americani, con una prevalenza globale del 14%. Questa patologia, caratterizzata da chiazze ruvide e squamose nelle zone esposte al sole, può evolvere in carcinoma a cellule squamose se non trattata. La campagna si svolgerà per tutto maggio 2025, con entrambe le aziende che effettueranno donazioni a The Skin Cancer Foundation a nome dei partecipanti.
Biofrontera Inc. (NASDAQ:BFRI) y Almirall han lanzado el Hats On Challenge, una iniciativa en redes sociales para aumentar la conciencia sobre la Queratosis Actínica (AK) antes del Día Mundial de Concienciación sobre AK el 24 de mayo de 2025. La campaña busca apoyar a The Skin Cancer Foundation y Euromelanoma mediante un desafío en redes sociales donde los participantes usan sombreros y publican videos con hashtags específicos.
La AK es una condición cutánea precancerosa común que afecta a aproximadamente 58 millones de estadounidenses, con una prevalencia global del 14%. Esta afección, caracterizada por parches ásperos y escamosos en áreas expuestas al sol, puede evolucionar a carcinoma de células escamosas si no se trata. La campaña se llevará a cabo durante todo mayo de 2025, y ambas compañías realizarán donaciones monetarias a The Skin Cancer Foundation en nombre de los participantes.
Biofrontera Inc. (NASDAQ:BFRI)와 Almirall이 Hats On Challenge라는 소셜 미디어 캠페인을 시작하여 2025년 5월 24일 세계 AK 인식의 날을 앞두고 광선각화증(AK)에 대한 인식을 높이고자 합니다. 이 캠페인은 참가자들이 모자를 쓰고 특정 해시태그를 사용하여 영상을 게시하는 소셜 미디어 챌린지를 통해 The Skin Cancer Foundation과 Euromelanoma를 지원하는 것을 목표로 합니다.
AK는 약 5,800만 명의 미국인이 앓고 있는 흔한 전암성 피부 질환으로, 전 세계 유병률은 14%입니다. 이 질환은 햇빛에 노출된 부위에 거칠고 비늘 모양의 반점이 생기는 것이 특징이며, 치료하지 않으면 편평세포암으로 발전할 수 있습니다. 캠페인은 2025년 5월 한 달 동안 진행되며, 두 회사는 참가자를 대신하여 The Skin Cancer Foundation에 금전적 기부를 할 예정입니다.
Biofrontera Inc. (NASDAQ:BFRI) et Almirall ont lancé le Hats On Challenge, une initiative sur les réseaux sociaux visant à sensibiliser sur la Kératose Actinique (AK) à l'approche de la Journée mondiale de sensibilisation à l'AK, le 24 mai 2025. La campagne soutient The Skin Cancer Foundation et Euromelanoma via un défi sur les réseaux sociaux où les participants portent des chapeaux et publient des vidéos avec des hashtags spécifiques.
L'AK est une affection cutanée précancéreuse courante qui touche environ 58 millions d'Américains, avec une prévalence mondiale de 14 %. Cette condition, caractérisée par des plaques rugueuses et squameuses sur les zones exposées au soleil, peut évoluer en carcinome épidermoïde si elle n'est pas traitée. La campagne se déroulera tout au long du mois de mai 2025, les deux entreprises faisant des dons financiers à The Skin Cancer Foundation au nom des participants.
Biofrontera Inc. (NASDAQ:BFRI) und Almirall haben die Hats On Challenge ins Leben gerufen, eine Social-Media-Initiative zur Sensibilisierung für Aktinische Keratose (AK) im Vorfeld des Globalen AK Awareness Day am 24. Mai 2025. Die Kampagne unterstützt die Skin Cancer Foundation und Euromelanoma durch eine Social-Media-Challenge, bei der Teilnehmer Hüte tragen und Videos mit bestimmten Hashtags posten.
AK ist eine häufige präkanzeröse Hauterkrankung, die schätzungsweise 58 Millionen Amerikaner betrifft und weltweit eine Prävalenz von 14 % aufweist. Die Erkrankung, die sich durch raue, schuppige Stellen an sonnenexponierten Hautstellen auszeichnet, kann unbehandelt zu einem Plattenepithelkarzinom führen. Die Kampagne läuft den gesamten Mai 2025, wobei beide Unternehmen im Namen der Teilnehmer Geld an die Skin Cancer Foundation spenden.
- None.
- None.
- The initiative is a social media challenge ahead of Global AK Awareness Day, on May 24, which supports the work of The Skin Cancer Foundation and Euromelanoma
- The Hats On Challenge provides an opportunity to take part in raising awareness of AK.
- Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. If left untreated, AK can develop into squamous cell carcinoma, a type of skin cancer.
Woburn, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), and Almirall, a global pharmaceutical company dedicated to medical dermatology announced today the launch of the Hats On Challenge, a new community-driven, social media based initiative aimed at enhancing awareness and support for actinic keratosis (AK).
Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. It often appears on sun-exposed areas such as the face, lips, ears, forearms, scalp, neck, decollete or back of the hands. If left untreated, AK can develop into squamous cell carcinoma, a type of skin cancer1.
AK is one of the most common diagnoses made by dermatologists2, with an estimated global prevalence of
In the lead-up to AK Global Awareness Day on May 24, both companies are rolling out a dedicated awareness and fundraising campaign. This campaign will highlight the importance of disease awareness within the dermatology community and the general public, focusing on the importance of prevention and treatment of actinic keratosis. Funds raised will support ongoing public awareness and patient education through The Skin Cancer Foundation. This organization will also highlight AK content on their social media channels in the days surrounding Global AK Awareness Day.
The Hats On Challenge—a social media initiative that encourages participants to wear a hat, post a video, and use the hashtags [#HatsOnForAK #GlobalAKDay #GuardYourSkinsMemories #ActinicKeratosis] to spread awareness about skin protection, highlight early signs of AK, and reinforce the importance of timely treatment. The initiative is aimed at supporting the work of The Skin Cancer Foundation and Euromelanoma.
"Actinic keratosis is a common precancerous skin condition that results from chronic sun exposure and can potentially lead to skin cancer if left untreated. It’s estimated that 58 million Americans have one or more AKs. We are grateful to Almirall and Biofrontera for their support of our efforts to educate the public about the prevention, warning signs, and treatment options of this condition.” – Deborah S. Sarnoff, MD, President of The Skin Cancer Foundation.
Join the Challenge
The Hats On Challenge will run through the month of May, and participants will be recognized through a monetary donation made to The Skin Cancer Foundation on behalf of Biofrontera and Almirall. This initiative underscores the importance of skin protection and the role of actinic keratosis in skin health.
Challenge Hashtag: #HatsOnForAK #GlobalAKDay #GuardYourSkinsMemories #ActinicKeratosis
For more information about the Hats On Challenge, please visit our team fundraising website https://give.skincancer.org/HatsOnForAK or follow us on social media Biofrontera Almirall.
About Actinic Keratosis
Actinic Keratosis (AK) is a rough, scaly patch on the skin caused by years of sun exposure. It often appears on sun-exposed areas such as the face, scalp, lips, ears, forearms, decollete, neck, or back of the hands. If left untreated, AK can develop into squamous cell carcinoma, a type of skin cancer1. The Skin Cancer Foundation emphasizes the importance of early detection and treatment to prevent the progression of AK.
About Biofrontera
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes a drug-device combination for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visit www.biofrontera-us.com
Helpful Resources
For more information about Actinic Keratosis, including prevention, detection, and treatment options, please visit The Skin Cancer Foundation's Actinic Keratosis page https://www.skincancer.org/skin-cancer-information/actinic-keratosis/
Contact:
Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
1 Skin Cancer Foundation. Actinic Keratosis Overview. Available at: https://www.skincancer.org/skin-cancer-information/actinic-keratosis/#:~:text=Actinic%20keratosis%20(AK)%20is%20the,to%20ultraviolet%20(UV)%20radiation
2 Wilmer EN, Gustafson CJ, Ahn CS, Davis SA, Feldman SR, Huang WW. Most common dermatologic conditions encountered by dermatologists and nondermatologists. Cutis. 2014;94(6):285-92.
3 Christopher D George, Truelian Lee, Loes M Hollestein, Maryam M Asgari, Tamar Nijsten, Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis, British Journal of Dermatology, Volume 190, Issue 4, April 2024, Pages 465–476.
FAQ
What is the Hats On Challenge launched by Biofrontera (BFRI) and Almirall?
When is Global AK Awareness Day 2025 and what is Biofrontera (BFRI) doing for it?
How many Americans are affected by Actinic Keratosis according to Biofrontera's campaign?
What is Actinic Keratosis and what are its risks?
